SANA Q2 2021 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

$19M

Net Income

$19M

EPS (Diluted)

$0.09

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$51M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$354M

Stockholders' Equity

$906M

Cash & Equivalents

$675M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	$19M	-$88M	+121.1%
Net Income	$19M	-$88M	+121.3%